期刊文献+

重症肌无力单链抗体基因的制备 被引量:6

Preparation of single chain variable fragment gene in myasthenia gravis
下载PDF
导出
摘要 [目的 ]构建抗人乙酰胆碱受体主要免疫原区单链抗体 .[方法 ]应用多聚酶链反应从抗人乙酰胆碱受体主要免疫原区抗原结合片段扩增重链和轻链可变区基因 ,并克隆到载体噬粒 pHEN2 .将含有单链抗体基因的重组噬粒转化大肠杆菌DH5α ,分离提纯重组噬粒后再经酶切、琼脂糖凝胶电泳检查以确认单链抗体基因的正确性 .[结果 ]电泳检查发现了大小分别为 3 78bp ,3 3 9bp和 762bp的重链可变区、轻链可变区和单链抗体基因 ,且位置正确 .[结论 OBJECTIVE?To construct the gene of a single chain variable fragment against the main immunogenic region in acetylcholine receptor.?METHODS?The heavy chain and light chain variable region genes were amplified from an human antigen binding fragment against the main immunogenic region in human acetylcholine receptor using PCR, and cloned in vector phagemid pHEN2. The recombinant phagemid containing the single chain variable fragment gene was subsequently transformed into E coli DH5α. After isolation and purification, the recombinant was digested with endonucleases and checked in agarose gel electrophoresis to confirm the right size of the single chain variable fragment.?RESULTS?The sizes of the heavy chain variable region gene, the light chain variable region gene and the single chain variable fragment gene were found to be approximately 378?bp, 339?bp and 762?bp respectively, and the inserted positions were correct.?CONCLUSION?A single chain variable fragment gene against the main immunogenic region in human acetylcholine receptor has been successfully constructed .
出处 《延边大学医学学报》 CAS 2002年第1期1-4,共4页 Journal of Medical Science Yanbian University
基金 国家自然科学基金 ( 3 9960 0 72 ) 教育部高等学校骨干教师资助计划基金
关键词 重症肌无力 单链抗体基因 制备 胆碱能受体 myasthenia gravis single chain variable fragment receptors, cholinergic
  • 相关文献

参考文献8

  • 1Graus Y, de Baets M. Myasthenia gravis: An autoim mune response against the acetylcholine receptor [J].Immunological Res, 1993,12: 78.
  • 2Tzartos SJ, Seybold ME, Lindstrom JM. Specificities of antibodies to acetylcholine receptors in sera from myas thenia gravis patients measured by monoclonal antibodies[J]. Proc Natl Acad Sci USA, 1982,79:188.
  • 3Graus Y, de Baets M, Parren P, et al.. Human antinicotinic acetylcholine receptor recombinant Fab frag ments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predomi nant specificities in serum and block the action of pathogenic serum antibodies[J]. J Immunol, 1997,158:1919.
  • 4杨康鹃,孟繁平,YGraus,MdeBaets.重组质粒对大肠杆菌 DH5_α 的转化[J].延边大学医学学报,1997,20(2):69-70. 被引量:3
  • 5Papanastasiou D, Mamalaki A, Eliopoulos E, et al.. Construction and characterization of an humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor[J]. J Neuroim munol, 1999,94:182.
  • 6Mamalaki A, Trakas N, Tzartos SJ. Bacterial expression of single-chain Fy fragment which efficiently protects the acetylcholine receptor against antigenic modulation caused by myasthenic antibodies[J]. Eur J Immunol, 1993,23: 1839.
  • 7Tsantili P, Tzartos SJ, Mamalaki A. High affinity sin gle-chain antibody fragments protecting the human nico tinic acetylcholine receptor [J]. J Neuroimmunol , 1999,94:15.
  • 8Tripathi PK, Qin H, Deng S, et al.. Antigen mimicry by an anti-idiotypic antibody single chain variable frag ment [ J ]. Mol Immunol, 1998,35 (13): 853.

共引文献2

同被引文献46

  • 1[1]Huston JS, Levinson D, Mudgett Hunter M, et al. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli [ J]. Proc Natl Acad Sci USA, 1988,85 (16): 5 879 - 5 883.
  • 2[3]Casey JL, Keep PA, Chester KA, et al. Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography [ J]. J Immunol Methods, 1995, 179 (1): 105 - 116.
  • 3[4]Luther MA, Schoepfer R, Whiting P, et al. A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671 [ J]. J Neurosci, 1989,9 (3): 1082-1096.
  • 4[5]Graus YF, de Baets MH, Parren PW, et al. Human antinicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies [J]. J Immunol, 1997, 158 (4): 1 919 - 1 929.
  • 5[8]Lamarre A, Yu MW, Chagnon F, et al. A recombinant single chain antibody neutralizes coronavirus infectivity but only slightly delays lethal infection of mice [ J ]. Eur J Immunol,1997, 27 (12): 3 447-3 455.
  • 6[9]Goel A, Colcher D, Koo JS, et al. Relative position of the hexahistidine tag effects binding properties of a tumor-associated single-chain Fv construct[J]. Biochim Biophys Acta,2000, 1 523 (1): 13-20.
  • 7[10]Long MC, Jager S, Mah DC, et al. Construction and characterization of a novel recombinant single-chain variable fragment antibody against western equine encephalitis virus [J]. Hybridoma, 2000, 19 (1): 1-13.
  • 8[11]Brown JC, Brown BA 2nd, Li Y, et al. Construction and characterization of a quadruplex DNA selective single-chain autoantibody from a viable motheaten mouse hybridoma with homology to telomeric DNA binding proteins [J]. Biochemistry, 1998, 37 (46): 16 338 - 16 348.
  • 9Huston JS, Levinson D, Mudgett-Hunter M, et al..Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli[J ]. Proc Natl Acad Sci USA,1988,85:5879.
  • 10Graus Y, de Baets M, Parren P, et al.. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies[J]. J Immunol 1997,158:1919.

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部